Use of tellurium containing compounds as nerve protecting agents
AssigneeBioMAS Ltd.
InventorsBenjamin Sredni, Michael Albeck
Life of this patent
Estimating the term…
Abstract
A novel neuroprotective agent is disclosed for the treatment and prevention of neurodegenerative disorders which is based on the administration of an effective amount of a tellurium compound which has a specific ability to induce the differentiation and interfere with apoptotic cell death pathways of neuronal PC-12 cells.
Claims33
A method for treating or preventing a neurodegenerative process in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of at least one tellurium-containing compound, said at least one tellurium-containing compound comprising at least one tellurium dioxide moiety.
A pharmaceutical composition comprising at least one tellurium-containing compound which comprises at least one tellurium dioxide moiety and a pharmaceutically acceptable carrier, the composition being packaged in a packaging material and identified in print, in or on the packaging material, for use in the treatment or prevention of a neurodegenerative process.
Dependencies are inferred from the claim text.